Literature DB >> 18636967

Tyrosine modification enhances metal-ion binding.

Graham S Baldwin1, Michael F Bailey, B Philip Shehan, Ioulia Sims, Raymond S Norton.   

Abstract

Tyrosine sulfation is a common modification of many proteins, and the ability to phosphorylate tyrosine residues is an intrinsic property of many growth-factor receptors. In the present study, we have utilized the peptide hormone CCK(8) (cholecystokinin), which occurs naturally in both sulfated and unsulfated forms, as a model to investigate the effect of tyrosine modification on metal-ion binding. The changes in absorbance and fluorescence emission on Fe(3+) binding indicated that tyrosine sulfation or phosphorylation increased the stoichiometry from 1 to 2, without greatly affecting the affinity (0.6-2.8 microM at pH 6.5). Measurement of Ca(2+) binding with a Ca(2+)-selective electrode revealed that phosphorylated CCK(8) bound two Ca(2+) ions. CCK(8) and sulfated CCK(8) each bound only one Ca(2+) ion with lower affinity. Binding of Ca(2+), Zn(2+) or Bi(3+) to phosphorylated CCK(8) did not cause any change in absorbance, but substantially increased the change in absorbance on subsequent addition of Fe(3+). The results of the present study demonstrate that tyrosine modification may increase the affinity of metal-ion binding to peptides, and imply that metal ions may directly regulate many signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18636967      PMCID: PMC2574882          DOI: 10.1042/BJ20081059

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

Review 1.  The gastrins: their production and biological activities.

Authors:  G J Dockray; A Varro; R Dimaline; T Wang
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

2.  Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.

Authors:  V Gigoux; B Maigret; C Escrieut; S Silvente-Poirot; M Bouisson; J A Fehrentz; L Moroder; D Gully; J Martinez; N Vaysse; A D Fourmy
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

3.  Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4.

Authors:  Chih-Chin Huang; Son N Lam; Priyamvada Acharya; Min Tang; Shi-Hua Xiang; Syed Shahzad-Ul Hussan; Robyn L Stanfield; James Robinson; Joseph Sodroski; Ian A Wilson; Richard Wyatt; Carole A Bewley; Peter D Kwong
Journal:  Science       Date:  2007-09-28       Impact factor: 47.728

4.  Evidence that interspecies polymorphism in the human and rat cholecystokinin receptor-2 affects structure of the binding site for the endogenous agonist cholecystokinin.

Authors:  Ingrid Langer; Irina G Tikhonova; Marie-Agnès Travers; Elodie Archer-Lahlou; Chantal Escrieut; Bernard Maigret; Daniel Fourmy
Journal:  J Biol Chem       Date:  2005-04-07       Impact factor: 5.157

5.  Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state.

Authors:  V Gigoux; C Escrieut; S Silvente-Poirot; B Maigret; L Gouilleux; J A Fehrentz; D Gully; L Moroder; N Vaysse; D Fourmy
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

6.  Improvements in the numerical analysis of thermodynamic data from biomolecular complexes.

Authors:  C A Royer
Journal:  Anal Biochem       Date:  1993-04       Impact factor: 3.365

7.  Direct identification of the agonist binding site in the human brain cholecystokininB receptor.

Authors:  J Anders; M Blüggel; H E Meyer; R Kühne; A M ter Laak; E Kojro; F Fahrenholz
Journal:  Biochemistry       Date:  1999-05-11       Impact factor: 3.162

8.  Calcium binding of phosphopeptides derived from hydrolysis of alpha s-casein or beta-casein using immobilized trypsin.

Authors:  O Park; H E Swaisgood; J C Allen
Journal:  J Dairy Sci       Date:  1998-11       Impact factor: 4.034

9.  BIOSYNTHESIS OF L-TYROSINE O-SULPHATE FROM THE METHYL AND ETHYL ESTERS OF L-TYROSINE.

Authors:  J G JONES; K S DODGSON
Journal:  Biochem J       Date:  1965-02       Impact factor: 3.857

10.  1H and 31P NMR spectroscopy of phosphorylated model peptides.

Authors:  R Hoffmann; I Reichert; W O Wachs; M Zeppezauer; H R Kalbitzer
Journal:  Int J Pept Protein Res       Date:  1994-09
View more
  5 in total

1.  Ferric ions inhibit proteolytic processing of progastrin.

Authors:  Gianni Bramante; Oneel Patel; Arthur Shulkes; Graham S Baldwin
Journal:  Biochem Biophys Res Commun       Date:  2010-12-30       Impact factor: 3.575

2.  Increased cholecystokinin labeling in the hippocampus of a mouse model of epilepsy maps to spines and glutamatergic terminals.

Authors:  M S Wyeth; N Zhang; C R Houser
Journal:  Neuroscience       Date:  2011-12-03       Impact factor: 3.590

3.  Phosphorylation of cyclin-dependent kinase 2 peptides enhances metal binding.

Authors:  Graham S Baldwin
Journal:  Biochem Biophys Res Commun       Date:  2008-12-25       Impact factor: 3.575

4.  Iron depletion results in Src kinase inhibition with associated cell cycle arrest in neuroblastoma cells.

Authors:  Gamini Siriwardana; Paul A Seligman
Journal:  Physiol Rep       Date:  2015-03

5.  Tyrosine modification increases the affinity of gastrin for ferric ions.

Authors:  Graham S Baldwin; Ioulia Sims
Journal:  Springerplus       Date:  2015-12-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.